The bio-nano-interface in predicting nanoparticle fate and behaviour in living organisms: Towards grouping and categorising nanomaterials and ensuring nanosafety by design

BioNanoMaterials

Volumn 14, Issue 3-4, 2013, Pages 195-216

  Boraschi, Diana ^a   Byrne, Hugh J ^b   Fadeel, Bengt ^c   Gehr, Peter ^d   Gutleb, Arno C ^e   Kendall, Michaela ^f   Papadopoulos, Manthos G ^g   Ahluwalia, Arti ^h  

^a INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF BERN   (Switzerland)

^e LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY   (Luxembourg)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g INSTITUTE OF BIOLOGY   (Greece)

^h UNIVERSITY OF PISA   (Italy)

Author keywords

biological identity; biomolecule corona; bionano interface; nanomedicine; nanoparticle; nanosafety; synthetic identity

Indexed keywords

EID: 85025260128     PISSN: 21930651     EISSN: 2193066X     Source Type: Journal    
DOI: 10.1515/bnm-2013-0011     Document Type: Article

References (148)

1. Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA. The nanoparticle-protein complex as a biologicalentity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci 2007;134–135:167–174.
2. Cedervall T, Lynch I, Lindman S, Nilsson H, Thulin E, Linse S, et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Nat Acad Sci 2007a;104:2050–2055.
3. Walczyk D., Baldelli-Bombelli F., Campbell A., Lynch I., Dawson K.A. What the Cell “Sees” in Bionanoscience. JACS 2010;132:5761–5768.
4. Stark WJ. Nanoparticles in Biological Systems. Angewandte Chemie International Edition 2011;50:1242–1258.
5. Dawson KA, Anguissola S, Lynch I. The need for in situ characterisation in nanosafety assessment: funded transnational access via the QNano research infrastructure. Nanotoxicology 2013;7:346–349.
6. Schürch S, Gehr P, Im Hof V, Geiser M, Green F. Surfactant displaces particles toward the epithelium in airways and alveoli. Respir Physiol 1990;80:17–32.
7. Kendall M, Hutton BM, Tetley TD, Nieuwenhuijsen M, Wigzell E, Jones F. Investigation of fine atmospheric particle surfaces and lung lining fluid interactions using XPS. Appl Surf Sci 2001;178:27–36.
8. Kendall M, Tetley TD, Wigzell E, Hutton B, Nieuwenhuijsen M, Luckham P. Lung lining liquid modifies PM2.5 in favour of particle aggregation: A protective mechanism. Am J Physiol: Lung 2002;282:L109–14.
9. Kendall M, Guntern J, Lockyer NP, Jones FH, Hutton BM, Lippmann M, et al. Urban PM2.5 surface chemistry and interactions with broncho-alveolar lavage fluid (BALF). J Inhal Tox 2004;16 (suppl. 1):115–129.
10. Kendall M, Brown L, Trought K. Molecular adsorption at particle surfaces: A PM toxicity mediation mechanism. J Inhal Tox 2004;16 (suppl. 1):99–105.
11. Kendall M, Holgate S. Exposure, dose, translocation and impacts of engineered nanomaterials in humans. Respirology 2012;17:743–758.
12. Kendall M. Fine airborne urban particles (PM2.5) sequester lung surfactant and amino acids from human lung lavage. Am J Physiol Lung Cell Mol Physiol 2007;293:L1053–8.
13. Meerasa A, Huang JG, Gu FX. Human serum lipoproteins influence protein deposition patterns on nanoparticle surfaces. ACS Appl Mater Interfaces 2013;5:489–493.
14. Yang S, Bar-Ilan O, Peterson RE, Heideman W, Hamers RJ, Pedersen JA. Influence of humic Acid on titanium dioxide nanoparticle toxicity to developing zebrafish. Environ Sci Technol 2013;47:4718–4725.
15. Gasser M, Rothen-Rutishauser B, Krug HF, Gehr P, Nelle M, Yan B, et al. The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry. J Nanobiotechnology 2010;8:31.
16. Park H, Grassian VH. Commercially manufactured engineered nanomaterials for environmental and health studies: Important insights provided by independent characterization. Environ Toxicol Chem 2010;29:715–721.
17. Quik JT, Lynch I, Van Hoecke K, Miermans CJ, De Schamphelaere KA, Janssen CR, et al. Effect of natural organic matter on cerium dioxide nanoparticles settling in model fresh water. Chemosphere 2010;81:711–715.
18. Baalousha M, Manciulea A, Cumberland S, Kendall K, Lead JR. Aggregation and surface properties of iron oxide nanoparticles: influence of pH and natural organic matter. Environ Toxicol Chem 2008;27:1875–1882.
19. Pelley AJ, Tufenkji N. Effect of particle size and natural organic matter on the migration of nano-and microscale latex particles in saturated porous media. J Colloid Interf Sci 2008;321:74–83.
20. OECD, Series on the Safety of Manufactured Nanomaterials, No. 27, List of manufactured nanomaterials and list of endpoints for phase one testing of the sponsorship programme for the testing of manufactured nanomaterials: revision. ENV/JM/ MONO(2010)46 2010.
21. Cukalevski R, Lundqvist M, Oslakovic C, Dahlback B, Linse S, Cedervall T. Structural changes in apolipoproteins bound to nanoparticles. Langmuir 2011;27:14360–14369.
22. Bailes J, Gazi S, Ivanova R, Soloviev M. Effect of gold nanoparticle conjugation on the activity and stability of functional proteins. Methods Mol Biol 2012;906:89–99.
23. Lesniak A, Fenaroli F, Monopoli MP, Aberg C, Dawson KA, Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 2012;6:5845–5857.
24. Lesniak A., Campbell A., Monopoli M.P., Lynch I., Salvati A., Dawson K.A. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 2010;31:9511–9518.
25. Maiorano G, Sabella S, Sorce B, Brunetti V, Malvindi MA, Cingolani R, et al. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano 2010;4:7481–7491.
26. Linse S, Cabaleiro-Lago C, Xue W-F, Lynch I, Lindman S, Thulin E, et al. Nucleation of protein fibrillation by nanoparticles. PNAS 2007;104:8691–8696.
27. Wang Y, Li Y, Costanza J, Abriola LM, Pennell KD. Enhanced mobility of fullerene (C60) nanoparticles in the presence of stabilizing agents. Environ Sci Technol 2012;46:11761–11769.
28. Mahon E, Hristov DR, Dawson KA. Stabilising fluorescent silica nanoparticles against dissolution effects for biological studies. Chem Commun (Camb) 2012;48:7970–7972.
29. Ge C, Du J, Zhao L, Wang L, Liu Y, Li D, et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci USA 2011;108:16968–16973.
30. Monopoli MP, Dorota Walczyk D, Lowry-Campbell A, Elia E, Lynch I, Bombelli FB, et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 2011;133:2525–2534.
31. Casey A, Herzog E, Lyng FM, Byrne HJ, Chambers G, Davoren M. SWCNT suppress inflammatory mediator responses in human lung epithelium in vitro. Toxicol Lett 2008;179: 78–84.
32. Salvati A, Pitek AS, Monopoli MP, Prapainop K, Bombelli FB, Hristov DR, et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 2013;8:137–143.
33. Damiano MG, Mutharasan RK, Tripathy S, McMahon KM, Thaxton CS. Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery. Adv Drug Deliv Rev 2012;65:649–662.
34. Lesniak A, Salvati A, Santos-Martinez MJ, Radomski MW, Dawson KA, Åberg C. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc 2013;135:1438–1444.
35. Shvedova AA, Kagan VE, Fadeel B. Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems. Annu Rev Pharmacol Toxicol 2010;50:63–88.
36. Klein J. Probing the interactions of proteins and nanoparticles. Proc Natl Acad Sci USA 2007;104:2029–2030.
37. Deng ZJ, Liang M, Toth I, Monteiro MJ, Minchin RF. Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. ACS Nano 2012;6:8962–8969.
38. Cedervall T, Lynch I, Foy M, Berggård T, Donnelly SC, Cagney G, et al. Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles. Angew Chem Int Ed 2007;46:5754–5756.
39. Krug HF, Wick P. Nanotoxicology: an interdisciplinary challenge. Angewandte Chemie Internat Ed 2011;50:1260–1278.
40. Rivera Gil P, Oberdörster G, Elder A, Puntes V, Parak WJ. Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. ACS Nano 2010;4:5527–5531.
41. Kendall M, Ding P, Kendall K. Particle and nanoparticle interactions with fibrinogen: the importance of aggregation in nanotoxicology. Nanotoxicology 2011;5:55–65.
42. Fadeel B, Feliu N, Vogt C, Abdelmonem AM, Parak WJ. Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013;5: 111–129.
43. Savolainen KB, Brouwer D, Fadeel B, Fernandes T, Kuhlbusch T, Landsiedel R, et al. Nanosafety in Europe 2015–2025: Towards safe and sustainable nanomaterials and nanotechnology innovations. FIOH: Finland, 2013.
44. Lundqvist M, Stigler J, Cedervall T, Berggård T, Flanagan M, Lynch I, et al. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 2011;5:7503–7509.
45. Lacerda SH, Park J, Meuse C, Pristinski D, Becker ML, Karim A, et al. Interaction of gold nanoparticles with common human blood proteins. ACS Nano 2009;4:365–379.
46. Schulze C, Schaefer UF, Ruge CA, Wohlleben W, Lehr C-M. Interaction of metal oxide nanoparticles with lung surfactant protein A. EJPB 2010;77:376–383.
47. Kendall M, Ding P, Mackay R-M, Madsen J, Deb R, MacKenzie Z, et al. Surfactant protein D alters cellular uptake of particles and nanoparticles. Nanotoxicology 2013;7:963–973.
48. Fleischer CC, Kumar U, Payne CK. Cellular binding of anionic nanoparticles is inhibited by serum proteins independent of nanoparticle composition. Biomater Sci 2013;1:975–982.
49. Lundqvist M, Stigler J, Cedervall T, Elia G, Lynch I, Dawson K. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. PNAS 2008;105:14265–14270.
50. Schäffler M, Semmler-Behnke M, Sarioglu H, Takenaka S, Wenk A, Schleh C, et al. Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles. Nanotechnology 2013;24:265103.
51. Jedlovszky-Hajdú A, Bombelli FB, Monopoli MP, Tombácz E, Dawson KA. Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo. Langmuir 2012;28:14983–14991.
52. Amiri H, Bordonali L, Lascialfari A, Wan S, Monopoli MP, Lynch I, et al. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles. Nanoscale 2013;5:8656–8665.
53. Walkey CD, Chan WC. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 2012;41:2780–2799.
54. Yang ST, Liu Y, Wang YW, Cao A. Biosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactions. Small 2013;9:1635–1653.
55. Hyung H, Fortner JD, Hughes JB, Kim JH. Natural organic matter stabilizes carbon nanotubes in the aqueous phase. Environ Sci Technol 2007;41:179–184.
56. French RA, Jacobson AR, Kim B, Isley SL, Penn RL, Baveye PC. Influence of ionic strength, pH, and cation valence on aggregation kinetics of titanium dioxide nanoparticles. Environ Sci Technol 2009;43:1354–1359.
57. Von Wandruszka R. The secondary structure of humic acid and its environmental implications. Washington, D.C.: US EPA, 1998.
58. Ogawara KF, Nagayama S, Minato K, Higaki K, Kai T, Kimura T. Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles. J Control Release 2004;100:451–455.
59. Lunov O, Syrovets T, Loos C, Beil J, Delacher M, Tron K, et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano 2011;5:1657–1669.
60. Geiser M, Rothen-Rutishauser BM, Kapp N, Schürch S, Kreyling W, Schulz H, et al. Ultrafine particles cross cellular membranes by non-phagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 2005;113:1555–1560.
61. Rothen-Rutishauser BM, Kiama SG, Gehr P. A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Amer J Respir Cell Molec Biol 2005;32:281–289.
62. Blank F, Gehr P, Rothen-Rutishauser B. Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Amer J Respir Cell Molec Biol 2007;36:669–677.
63. Blank F, Rothen-Rutishauser B, Schürch S, Gehr P. An optimized in vitro model of the respiratory tract wall to study particle cell interactions. J Aerosol Med 2006;19:392–405.
64. Kreyling WG, Semmler M, Erbe F, Mayer S, Takenaka S, Schultz J. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. Toxicol Env Health Part A 2002;65:1513–1530.
65. Kreyling WG, Semmler-Behnke M, Seitz J, Scymczak W, Wenk A, Mayer P, et al. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol 2009;21(S1):55–60.
66. Gehr P, Green FH, Geiser M, Im Hof V, Lee MM, Schürch S. Airway surfactant, a primary defense barrier: mechanical and immunological aspects. J Aerosol Med 1996;9:163–181.
67. Ruge CA, Schaefer UF, Herrmann J, Kirch J, Cañadas O, Echaide M, et al. The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLoS ONE 2012;7:e40775.
68. Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J, Schäffler M, et al. Particle size-dependent and surface chargedependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm 2011;77:407–416.
69. Kunzmann A, Andersson B, Thurnherr T, Krug HF, Scheynius A, Fadeel B. Toxicology of engineered nanomaterials: Focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 2011;1810:361–373.
70. Kunzmann A, Andersson B, Vogt C, Feliu N, Ye F, Gabrielsson S, et al. Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol Appl Pharmacol 2011;253:81–93.
71. Konczol M, Ebeling S, Goldenberg E, Treude F, Gminski R, Giere R, et al. Cytotoxicity and genotoxicity of sizefractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-kappaB. Chem Res Toxicol 2011;24:1460–1475.
72. Gao J, Xu B. Applications of nanomaterials inside cells. Nano Today 2009;4:37–51.
73. Treuel L, Xiue Jiang X, Nienhaus GU. New views on cellular uptake and trafficking of manufactured nanoparticles. J R Soc Interface 2013;10:20120939.
74. Limbach LK, Wick P, Manser P, Grass RN, Bruinink A, Stark WJ. Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ Sci Technol 2007;41:4158–4163.
75. Shapero K., Fenaroli F., Lynch I., Cottell D.C., Salvati A., Dawson K.A. Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst 2011;7:371–378.
76. Salvati AA, dos Santos T, Varela J, Pinto P, Lynch I, Dawson KA. Experimental and theoretical approach to comparative nanoparticle and small molecule intracellular import, translocation, and export. NanoMedicine 2011;7:818–826.
77. Higuchi Y, Wu C, Chang KL, Irie K, Kawakami S, Yamashita F, et al. Polyamidoamine dendrimer-conjugated quantum dots for efficient labeling of primary cultured mesenchymal stem cells. Biomaterials 2011;32:6676–6682.
78. Han M, Kickhoefer VA, Nemerow GR, Rome LH. Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm. ACS Nano 2011;5:6128–6137.
79. Mukherjee SP, Lyng FM, Garcia A, Davoren M, Byrne HJ. Mechanistic studies of in vitro cytotoxicity of Poly(amidoamine) dendrimers in mammalian cells. Toxicol Appl Pharm 2010;248:259–268.
80. Wang T, Bai J, Jiang X, Nienhaus U. Cellular uptake of nanoparticles by membrane penetration: a study combining confocal microscopy with FTIR spectroelectrochemistry. ACS Nano 2012;6:1251–1259.
81. Brandenberger C, Müller C, Ali Z, Lenz A-G, Schid O, Parak WJ, et al. Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. Small 2010;6:1669–1678.
82. dos Santos T., Varela J., Lynch I., Salvati A., Dawson K.A. Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One 2011;6:e24438.
83. Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdörster G, McGrath JL. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 2009;30:603–610.
84. Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, et al. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 2002;10:317–325.
85. Kreuter J. Influence of the surface properties on nanoparticlemediated transport of drugs to the brain. J Nanosci Nanotechnol 2004;4:484–488.
86. Zaki NM, Tirelli N. Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting. Expert Opin Drug Deliv 2010;7:895–913.
87. Hillaireau H, Couvreur P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 2009;66:2873–2896.
88. Lin A, Sabnis A, Kona S, Nattama S, Patel H, Dong JF, et al. Shear-regulated uptake of nanoparticles by endothelial cells and development of endothelial-targeting nanoparticles. J Biomed Mater Res A 2010;93:833–842.
89. Vincent A, Babu S, Heckert E, Dowding J, Hirst SM, Inerbaev TM, et al. Protonated nanoparticle surface governing ligand tethering and cellular targeting. ACS Nano 2009;3:1203–1211.
90. Sandin P, Fitzpatrick LW, Simpson JC, Dawson KA. High-speed imaging of rab family small gtpases reveals rare events in nanoparticle trafficking in living cells. ACS Nano 2012;6: 1513–1521.
91. Jin H, Heller DA, Strano MS. Single-particle tracking of endocytosis and exocytosis of single-walled carbon nanotubes in NIH-3T3 cells. Nano Lett 2008;8:1577–1585.
92. Chithrani BD, Chan WC. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 2007;7:1542–1550.
93. Hirano S. A current overview of health effect research on nanoparticles. Environ Health Prev Med 2009;14:223–225.
94. Schins RP, Knaapen AM. Genotoxicity of poorly soluble particles. Inhal Toxicol 2007;19(Suppl 1):189–198.
95. Chan JK, Vogel CF, Baek J, Kodani SD, Uppal RS, Bein KJ, et al. Combustion derived ultrafine particles induce cytochrome P450 expression in specific lung compartments in the developing neonatal and adult rat. Am J Physiol Lung Cell Mol Physiol 2013;304:L665–77.
96. Park KH, Chhowalla M, Iqbal Z, Sesti F. Single-walled carbon nanotubes are a new class of ion channel blockers. J Biol Chem 2003;278:50212–50216.
97. Vranic S, Boggetto N, Contremoulins V, Mornet S, Reinhardt N, Marano F, et al. Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry. Part Fibre Toxicol 2013;10:2.
98. Bhabra G, Sood A, Fisher B, Cartwright L, Saunders M, Evans WH, et al. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol 2009;4:876–883.
99. Sood A, Salih S, Roh D, Lacharme-Lora L, Parry M, Hardiman B, et al. Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness. Nat Nanotechnol 2011;6:824–833.
100. Weyand B, von Schroeder HP. Altered VEGF-A and receptor mRNA expression profiles, and identification of VEGF144 in foetal rat calvaria cells, in coculture with microvascular endothelial cells. Cell Biol Int 2013;37:713–724.
101. Nic Ragnaill M, Bramini M, Ye D, Couraud PO, Romero IA, Weksler B, et al. Paracrine signalling of inflammatory cytokines from an in vitro Blood Brain Barrier upon exposure to polymeric nanoparticles. Analyst. 2013 Nov 5. [Epub ahead of print].
102. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005;113:823–839.
103. McKim JM. Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance. Comb Chem High Throughput Screen 2010;13:188–206.
104. Lavelle C, Berry H, Beslon G, Ginelli F, Giavitto J-L, Kapoula Z, et al. From molecules to organisms: towards multiscale integrated models of biological systems. Theoretical Biology Insights 2008;1:13–22.
105. Bassingthwaighte JB, Chizeck HJ, Atlas LE. Strategies and tactics in multiscale modeling of cell-to-organ systems. Proc IEEE Inst Electr Electron Eng 2006;94:819–830.
106. Díaz-Zuccarini V, Lawford PV. An in-silico future for the engineering of functional tissues and organs. Organogenesis 2010;6:245–251.
107. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 2006;6:1794–1807.
108. Shvedova AA, Pietroiusti A, Fadeel B, Kagan VE. Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress. Toxicol Appl Pharmacol 2012;261:121–133.
109. Mailloux RJ, Bériault R, Lemire J, Singh R, Chénier DR, Hamel RD, et al. The tricarboxylic acid cycle, an ancient metabolic network with a novel twist. PLoS One 2007;1:e690.
110. Ahamed M, Akhtar MJ, Siddiqui MA, Ahmad J, Musarrat J, Al-Khedhairy AA, et al. Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells. Toxicology 2011;283:101–108.
111. Ge Y, Bruno M, Wallace K, Winnik W, Prasad RY. Proteome profiling reveals potential toxicity and detoxification pathways following exposure of BEAS-2B cells to engineered nanoparticle titanium dioxide. Proteomics 2011;11:2406–2422.
112. Bexiga MG, Varela JA, Wang F, Fenaroli F, Salvati A, Lynch I, et al. Cationic nanoparticles induce caspase 3 and 7-mediated cytotoxicity in a human astrocytoma cell line. Nanotoxicology 2011;5:557–567.
113. Wang F., Yu L., Salvati A., Dawson K.A. The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine 2013;S1549–9634:00182–2.
114. Mukherjee SP, Byrne HJ. Polyamidoamine dendrimer nanoparticle cytotoxicity, oxidative stress, caspase activation and infammatory response: experimental observation and numerical simulation. Nanomedicine: Nanotechnology, Biology, and Medicine 2013;9:202–211.
115. Tsai YY, Huang YH, Chao YL, Hu KY, Chin LT, Chou SH, et al. Identification of the nanogold particle-induced endoplasmic reticulum stress by omic techniques and systems biology analysis. ACS Nano 2011;5:9354–9369.
116. Deng ZJ, Mingtao Liang M, Monteiro M, Toth I, Minchin RF. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 (CD11b/CD18) receptor activation and pro-inflammatory cytokine release. Nat Nanotechnol 2010;6:39–44.
117. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 2009;20:455101.
118. Love SA, Haynes CL. Assessment of functional changes in nanoparticle-exposed neuroendocrine cells withamperometry: exploring the generalizability of nanoparticle-vesicle matrix interactions. Anal Bioanal Chem 2010;398:677–688.
119. Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science 2006;311:622–627.
120. Parry MC, Bhabra G, Sood A, Machado F, Cartwright L, Saunders M, et al. Thresholds for indirect DNA damage across cellular barriers for orthopaedic biomaterials. Biomaterials 2010;31:4477–4483.
121. Kagan VE, Konduru NV, Feng W, Allen BL, Conroy J, Volkov Y, et al. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat Nano 2010;5:354–359.
122. Dell'Orco D, Lundqvist M, Cedervall T, Linse S. Delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening. Nanomed: Nanotech Bio Med 2012;8:1271–1281.
123. Shannahan JH, Lai X, Ke PC, Podila R, Brown JM, Witzmann FA. Silver nanoparticle protein corona composition in cell culture media. PLoS One 2013;8:e74001.
124. Kneipp K, Haka AS, Kneipp H, Badizadegan K, Yoshizawa N, Boone C, et al. Surface-enhanced raman spectroscopy in single living cells using gold nanoparticles. Appl Spectrosc 2002;56:150–154.
125. Kneipp J, Kneipp H, McLaughlin M, Brown D, Kneipp K. In vivo molecular probing of cellular compartments with gold nanoparticles and nanoaggregates. Nano Lett 2006;6: 2225–2231.
126. Kneipp J, Kneipp H, Rajadurai A, Redmond RW, Kneipp K. Optical probing and imaging of live cells using SERS labels. J Raman Spectrosc 2009;40:1–5.
127. Kneipp J, Kneipp H, Rice WL, Kneipp K. Optical probes for biological applications based on surface-enhanced Raman scattering from indocyanine green on gold nanoparticles. Anal Chem 2005;77:2381–2385.
128. Kneipp J, Kneipp H, Wittig B, Kneipp K. Novel optical nanosensors for probing and imaging live cells. J Phys Chem C 2010;114:7421–7426.
129. Dorney J, Bonnier F, Garcia A, Casey A, Chambers G, Byrne HJ. Identifying and localizing intracellular nanoparticles using raman spectroscopy. Analyst 2012;137:1111–1119.
130. Kendall K, Du S, Morris S, Sweet S. Virus concentration and adhesion measured by laser tracking. J Adhesion 2010;86:1029–1040.
131. Johnson KL, Kendall K, Roberts AD. Surface energy and the contact of elastic solids. Proc R Soc London 1971;A324:301–313.
132. Rong W, Ding W, Mädler L, Ruoff RS, Friedlander SK. Mechanical properties of nanoparticle chain aggregates by combined AFM and SEM: isolated aggregates and networks. NanoLett 2006;6:2646–2655.
133. Kendall K, Kendall M, Rehfeldt F. Adhesion of Cells, Viruses and Nanoparticles. Dordrecht, Heidelberg, London, New York: Springer, 2011.
134. Medina-Kauwe LK. “Alternative” endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery? Adv Drug Deliv Rev 2007;59:798–809.
135. Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004;306:640–643.
136. Janes KA, Albeck JG, Gaudet S, Sorger PK, Lauffenburger DA, Yaffe MB. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 2005;310:1646–1653.
137. Ito T, Chiba T, Yoshida M. Exploring the protein interactome using comprehensive two-hybrid projects. Trends Biotechnol. 2001;19(10 Suppl):S23–7.
138. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005;122:957–968.
139. Xia XR, Monteiro-Riviere NA, Riviere JE. An index for characterization of nanomaterials in biological systems. Nat Nanotechnol 2010;5:671–675.
140. Saptarshi SR, Duschl A, Lopata AL. Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnol 2013;11:26.
141. Lynch I, Dawson KA, Linse S. Detecting cryptic epitopes created by nanoparticles. Science Signaling 2006;2006:14.
142. Wilkinson K, Ekstrand-Hammarström B, Ahlinder L, Guldevall K, Pazik R, Kêpiñski L, et al. Visualization of custom-tailored iron oxide nanoparticles chemistry, uptake, and toxicity. Nanoscale 2012;4:7383–7393.
143. Röcker C, Pötzl M, Zhang F, Parak WJ, Nienhaus GU. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat Nanotechnol 2009;4:577–580.
144. Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol 2013;8:772–781.
145. European Academies Science Advisory Council, E., and European Commission Joint Research Centre (JRC) Joint EASAC-JRC Report, September 2011; 2011.
146. Scientific Committee on Emerging and Newly Identified Health Risks SCENIHR Opinion on Risk Assessment of Products of Nanotechnologies; 2009.
147. van der Bij S, Schaake E, Koffijberg H, Burgers JA, de Mol BA, Moons KG. Markers for the non-invasive diagnosis of mesothelioma: a systematic review. Br J Cancer 2011;104: 1325–1333.
148. Lynch I. Are there generic mechanisms governing interactions between nanoparticles and cells? Epitope mapping the outer layer of the protein-material interface. Physica A 2007;373:511–520.